Vertex and Arbor Biotechnologies partner to develop novel ex-vivo engineered cell therapies EP News Bureau Aug 25, 2021 Vertex to use Arbor’s CRISPR gene-editing technology to enhance efforts in developing novel cell therapies for the treatment of…
Merck licenses CRISPR gene-editing technology to Evotec EP News Bureau Nov 14, 2019 The licence is to accelerate research, enable testing and development of new drugs
